16
Jun
2026

Zhejiang Supor Pharmaceuticals Co., Ltd

Exhibitor at CPHI & PMEC China 2026 stand W2C30a, Pharma Ingredients
About Us

Zhejiang Supor Pharmaceuticals now is belonging to SyncoZymes Group, which is specialized among enzymes, intermediates, APIs and FDF. enjoying the advantages from group company`s biocatalytic technology development and chemical-enzymatic synthesis process development, Supor Pharma could deliver to our clients with APIs with cost competitiveness, quality management and sustainability ensurance by leading synthetic biology technology and green manufacturing.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    China
  • On CPHI since:
    2015
  • Certificates:
    2
  • Employees:
    250 - 499
Company types
Manufacturer/Innovator
Primary activities
Generic APIs producer
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI & PMEC China 2026
  • 16 Jun 2026 - 18 Jun 2026
  • Shanghai New International Expo Center
  • Visit us at stand W2C30a, Pharma Ingredients

Products Featured at CPHI & PMEC China 2026

  • quetiapine fumarate

    Product quetiapine fumarate

    This product is with US FDA and EU EDQM approvals, CEP, DMF, GMP and other international certificates are available.
  • bupropion HCL

    Product bupropion HCL

    This product has passed US FDA inspection, the DMF and other international certificates are available.
  • felodipine

    Product felodipine

    The product has been approved by US FDA, CEP DMF and GMP are available.
  • Tinidazole

    Product Tinidazole

    The product has been approved by US FDA and EU EDQM, local GMP , EU  GMP, CEP and DMF are available.
  • olanzapine

    Product olanzapine

    Zhejiang Supor Pharmaceuticals Co. Ltd offers a wide range of products which includes olanzapine. It belongs to API category. Contact us for more information.